Ensysce Biosciences, INC DEF 14A proxy statements

Ensysce Biosciences, Inc. has filed definitive additional proxy soliciting materials with the SEC.

Ensysce Biosciences, Inc. calls for its Annual Meeting on December 23, 2025, to seek stockholder approval for a significant equity issuance to an institutional investor, an increase in its incentive plan share reserve, and director elections.

Ensysce Biosciences has issued a supplement to its proxy statement clarifying that brokers have discretionary voting authority on Proposals 2, 4, and 5 at the upcoming annual meeting.

Ensysce Biosciences, Inc. has filed a definitive proxy statement with the SEC.

Ensysce Biosciences is holding a virtual annual meeting on November 21, 2024, to vote on proposals including share issuance approval, a reverse stock split, director elections, and auditor ratification.